These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 27760754)

  • 1. Lysophosphatidic acid-induced vascular neointimal formation in mouse carotid arteries is mediated by the matricellular protein CCN1/Cyr61.
    Hao F; Zhang F; Wu DD; An D; Shi J; Li G; Xu X; Cui MZ
    Am J Physiol Cell Physiol; 2016 Dec; 311(6):C975-C984. PubMed ID: 27760754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRE and SRE mediate LPA-induced CCN1 transcription in mouse aortic smooth muscle cells.
    Dou Q; Hao F; Sun L; Xu X; Cui MZ
    Can J Physiol Pharmacol; 2017 Mar; 95(3):275-280. PubMed ID: 28157379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matricellular protein Cyr61 bridges lysophosphatidic acid and integrin pathways leading to cell migration.
    Wu DD; Zhang F; Hao F; Chun J; Xu X; Cui MZ
    J Biol Chem; 2014 Feb; 289(9):5774-83. PubMed ID: 24371135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidic acid receptors LPA1 and LPA3 promote CXCL12-mediated smooth muscle progenitor cell recruitment in neointima formation.
    Subramanian P; Karshovska E; Reinhard P; Megens RT; Zhou Z; Akhtar S; Schumann U; Li X; van Zandvoort M; Ludin C; Weber C; Schober A
    Circ Res; 2010 Jul; 107(1):96-105. PubMed ID: 20360252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidic acid receptors 1 and 2 play roles in regulation of vascular injury responses but not blood pressure.
    Panchatcharam M; Miriyala S; Yang F; Rojas M; End C; Vallant C; Dong A; Lynch K; Chun J; Morris AJ; Smyth SS
    Circ Res; 2008 Sep; 103(6):662-70. PubMed ID: 18703779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidic acid-induced arterial wall remodeling: requirement of PPARgamma but not LPA1 or LPA2 GPCR.
    Cheng Y; Makarova N; Tsukahara R; Guo H; Shuyu E; Farrar P; Balazs L; Zhang C; Tigyi G
    Cell Signal; 2009 Dec; 21(12):1874-84. PubMed ID: 19709640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LPA
    Dancs PT; Ruisanchez É; Balogh A; Panta CR; Miklós Z; Nüsing RM; Aoki J; Chun J; Offermanns S; Tigyi G; Benyó Z
    FASEB J; 2017 Apr; 31(4):1547-1555. PubMed ID: 28069828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-mediated vascular smooth muscle migration induced by LPA involves p38 mitogen-activated protein kinase pathway activation.
    Zhou ZB; Niu JP; Zhang ZJ
    Int J Mol Sci; 2009 Jul; 10(7):3194-3208. PubMed ID: 19742132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
    Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LPA
    Hao F; Liu Q; Zhang F; Du J; Dumire A; Xu X; Cui MZ
    J Biol Chem; 2021 Oct; 297(4):101152. PubMed ID: 34478715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
    Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq.
    Kim J; Keys JR; Eckhart AD
    Cell Signal; 2006 Oct; 18(10):1695-701. PubMed ID: 16504475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation.
    Duran-Prado M; Morell M; Delgado-Maroto V; Castaño JP; Aneiros-Fernandez J; de Lecea L; Culler MD; Hernandez-Cortes P; O'Valle F; Delgado M
    Circ Res; 2013 May; 112(11):1444-55. PubMed ID: 23595952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global Proteomics Analysis of Lysophosphatidic Acid Signaling in PC-3 Human Prostate Cancer Cells: Role of CCN1.
    Balijepalli P; Yue G; Prasad B; Meier KE
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCN1 knockdown suppresses neointimal hyperplasia in a rat artery balloon injury model.
    Matsumae H; Yoshida Y; Ono K; Togi K; Inoue K; Furukawa Y; Nakashima Y; Kojima Y; Nobuyoshi M; Kita T; Tanaka M
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1077-83. PubMed ID: 18388330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells.
    Yu S; Murph MM; Lu Y; Liu S; Hall HS; Liu J; Stephens C; Fang X; Mills GB
    J Natl Cancer Inst; 2008 Nov; 100(22):1630-42. PubMed ID: 19001604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
    Chen M; Towers LN; O'Connor KL
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The early- and late stages in phenotypic modulation of vascular smooth muscle cells: differential roles for lysophosphatidic acid.
    Guo H; Makarova N; Cheng Y; E S; Ji RR; Zhang C; Farrar P; Tigyi G
    Biochim Biophys Acta; 2008 Sep; 1781(9):571-81. PubMed ID: 18602022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of lysophosphatidic acid receptors in phenotypic modulation of vascular smooth muscle cells.
    Zhou Z; Niu J; Zhang Z
    Mol Biol Rep; 2010 Jul; 37(6):2675-86. PubMed ID: 19757175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential targeting of lysophosphatidic acid LPA
    Olianas MC; Dedoni S; Onali P
    Eur J Pharmacol; 2023 Nov; 959():176064. PubMed ID: 37758013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.